BioCentury | Oct 11, 2016
Company News

Management tracks

...mRNA company CureVac AG (Tuebingen, Germany) hired Pierre Kemula as CFO. He was CFO at Pixium Vision S.A....
BioCentury | May 11, 2015
Finance

Debuting Biocartis

...Theradiag S.A. (Euronext:ALTER) 12/6/12 $10.7 -2% -41% Adocia S.A. (Euronext:ADOC; Pink:ADOCY) 2/14/12 $36.3 -2% 306% Pixium Vision S.A....
BioCentury | Jan 12, 2015
Company News

GenSight Biologics, Pixium Vision, Fondation Voir et Entendre deal

...begin clinical testing of PRIMA by end of 2016. GenSight Biologics Inc. , Paris, France Pixium Vision S.A....
BioCentury | Jul 28, 2014
Financial News

Pixium Vision financial update

Pixium Vision S.A. (Euronext:PIX), Paris, France Business: Ophthalmic Date announced: 2014-07-17 Note: Pixium raised EUR5 million ($6.7 million) through the sale of 598,575 shares at EUR8.28 to cover the overallotment from its June 17 IPO,...
BioCentury | Jul 14, 2014
Finance

3Q14 Financial Markets Preview: Discerning optimism

...Ltd. (NASDAQ:PARN) 6/18/14 $50.0 $132.8 $91.7 -31% Zafgen Inc. (NASDAQ:ZFGN) 6/18/14 $96.0 $348.9 $431.3 24% Pixium Vision S.A....
BioCentury | Jun 23, 2014
Finance

Highlights of weekly biotech stock moves

...at $132.8 million. Earlier this month, Parnell proposed to sell 3.2 million shares at $17-$19. Pixium Vision S.A....
BioCentury | Jun 23, 2014
Financial News

Pixium Vision completes IPO

Pixium Vision S.A. (Euronext:PIX), Paris, France Business: Ophthalmic Date completed: 2014-06-17 Type: IPO Raised: EUR34.5 million ($46.7 million) Shares: 4.2 million Price: EUR8.28 Shares after offering: 12.1 million Underwriters: Societe Generale; Jefferies; Gilbert Dupont Overallotment:...
BioCentury | Jun 19, 2014
Financial News

Ophthalmic play Pixium raises EUR 34.5M in Euronext IPO

...the implant to stimulate the optic nerve. IRIS is in a European clinical trial, and Pixium Vision...
BioCentury | Jun 9, 2014
Financial News

Pixium Vision S.A. amends IPO

Pixium Vision S.A. , Paris, France Business: Ophthalmic Date announced: 6/3/14 Type: IPO To be raised: Up to €36.7 million ($49.9 million) Shares: 3.6 million Price: €8.28-€10.12 Underwriters: Societe Generale; Jefferies; Gilbert Dupont Overallotment: 624,999 Note:...
BioCentury | Jun 3, 2014
Financial News

Ophthalmic play Pixium sets terms for Euronext IPO

...the implant to stimulate the optic nerve. IRIS is in a European clinical trial, and Pixium Vision...
Items per page:
1 - 10 of 19
BioCentury | Oct 11, 2016
Company News

Management tracks

...mRNA company CureVac AG (Tuebingen, Germany) hired Pierre Kemula as CFO. He was CFO at Pixium Vision S.A....
BioCentury | May 11, 2015
Finance

Debuting Biocartis

...Theradiag S.A. (Euronext:ALTER) 12/6/12 $10.7 -2% -41% Adocia S.A. (Euronext:ADOC; Pink:ADOCY) 2/14/12 $36.3 -2% 306% Pixium Vision S.A....
BioCentury | Jan 12, 2015
Company News

GenSight Biologics, Pixium Vision, Fondation Voir et Entendre deal

...begin clinical testing of PRIMA by end of 2016. GenSight Biologics Inc. , Paris, France Pixium Vision S.A....
BioCentury | Jul 28, 2014
Financial News

Pixium Vision financial update

Pixium Vision S.A. (Euronext:PIX), Paris, France Business: Ophthalmic Date announced: 2014-07-17 Note: Pixium raised EUR5 million ($6.7 million) through the sale of 598,575 shares at EUR8.28 to cover the overallotment from its June 17 IPO,...
BioCentury | Jul 14, 2014
Finance

3Q14 Financial Markets Preview: Discerning optimism

...Ltd. (NASDAQ:PARN) 6/18/14 $50.0 $132.8 $91.7 -31% Zafgen Inc. (NASDAQ:ZFGN) 6/18/14 $96.0 $348.9 $431.3 24% Pixium Vision S.A....
BioCentury | Jun 23, 2014
Finance

Highlights of weekly biotech stock moves

...at $132.8 million. Earlier this month, Parnell proposed to sell 3.2 million shares at $17-$19. Pixium Vision S.A....
BioCentury | Jun 23, 2014
Financial News

Pixium Vision completes IPO

Pixium Vision S.A. (Euronext:PIX), Paris, France Business: Ophthalmic Date completed: 2014-06-17 Type: IPO Raised: EUR34.5 million ($46.7 million) Shares: 4.2 million Price: EUR8.28 Shares after offering: 12.1 million Underwriters: Societe Generale; Jefferies; Gilbert Dupont Overallotment:...
BioCentury | Jun 19, 2014
Financial News

Ophthalmic play Pixium raises EUR 34.5M in Euronext IPO

...the implant to stimulate the optic nerve. IRIS is in a European clinical trial, and Pixium Vision...
BioCentury | Jun 9, 2014
Financial News

Pixium Vision S.A. amends IPO

Pixium Vision S.A. , Paris, France Business: Ophthalmic Date announced: 6/3/14 Type: IPO To be raised: Up to €36.7 million ($49.9 million) Shares: 3.6 million Price: €8.28-€10.12 Underwriters: Societe Generale; Jefferies; Gilbert Dupont Overallotment: 624,999 Note:...
BioCentury | Jun 3, 2014
Financial News

Ophthalmic play Pixium sets terms for Euronext IPO

...the implant to stimulate the optic nerve. IRIS is in a European clinical trial, and Pixium Vision...
Items per page:
1 - 10 of 19